This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

DNA Microarray 2013: A Focus On Sales Growth

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

DNA Microarray 2013: A Focus on Sales Growth

http://www.reportlinker.com/p0980749/DNA-Microarray-2013-A-Focus-on-Sales-Growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genetically_Modified_Organism,_GMO

DNA Microarray 2013 presents the findings of a global market study of DNA Microarray, involving the participation of 201 buyers and end-users in this field. With a focus on market development, sales growth and commercial opportunities, the study profiled current and evolving areas of this market, as outlined below. Its findings provide valuable product and market information, and decision-making support to suppliers in the DNA Microarray field.

From the early use of miniaturised microarrays for the analysis of gene expression in the mid 1990s, this technique has established markets that are expected to reach $3 billion by 2015. However, these are also changing as new applications are developed and new competitive strategies, such as PCR, grow. This report, based on an analysis of current and evolving developments in the DNA microarray field, has been produced to assist marketing and sales in this field, and the identification of new opportunities. It is the outcome of an extensive global study involving more than 200 experienced DNA microarray buyers and end-users. It's findings provide a "focus on sales growth" to developers and vendors in the microarray field, and the changes that are driving these developments. The following indicate the key market areas covered in the study:

  • Routine use: Use of DNA microarrays by end-users for running routine (developed and validated) microarray tests, the development or validation of microarray tests and for the qualitative discovery using microarray methods
  • Suppliers: Purchases of DNA microarrays and related systems by end-users from more than 30 companies and anticipated DNA microarray purchases by end-users from more than 30 companies over the next three years, each ranked according to their competitive position.
  • Methods: Current use of more than 15 DNA microarray methods by end-users and the anticipated use of these methods by end-users over the next three years, each ranked according to their competitive position.
  • Applications: Current use of more than 20 DNA microarray applications by end-users and the anticipated use of these applications by end-users over the next three years, each ranked according to their competitive position.
  • Preferred Companies: End-users' preferred companies in the DNA microarray field, each ranked according to their competitive position.
  • Products: End-users' preferred products (and associated companies) in the DNA microarray field, each ranked according to their competitive position.
  • Strengths: End-users' disclosures of the strengths of their preferred products in the DNA microarray field, each ranked according to their competitive position.
  • Weaknesses: End-users' disclosures of the weaknesses of their preferred products in the DNA microarray field, each ranked according to their relative position.
  • Financial Budgets: End-users' annual financial budgets for DNA microarray studies.
  • Budget Breakdown: The breakdown of end-users' DNA microarray financial budgets in eight key areas, relating to their current expenditure on DNA microarray products and activities.
  • Future Budget Breakdown: The breakdown of end-users' microarray financial budgets in eight key areas, relating to their anticipated expenditure over the next three years, on DNA microarray products and activities.
  • Future Budgets: End-users' anticipated changes (percentage increases or decrease) over the next three years, relating to their DNA microarray activities
  • Consumables: End-users' top three consumables, associated with their DNA microarray activities.
  • Quality Control: End-users' adherence to established quality control guidelines or procedures (e.g. MAIME), relating to the conduct of DNA microarray studies.
  • Challenges: End-users' disclosures on molecular types that present the greatest technical challenges to DNA microarray analysis, together with the associated sample types (matrices), associated microarray methods and underlying reasons.
  • Innovation: End-users' current needs relating to 12 key areas of required innovation in the DNA microarray field, each ranked (on a scale of 1 to 10) according to their importance.
  • Recent Innovations: End-users disclosures on the most important innovations relating to their use of DNA microarrays, over the last three years.
  • Future Innovation: End-users' disclosures on what they anticipate will be the most important innovations in the DNA microarray field, over the next three years.
  • Biomarkers: End-users' application of DNA microarray methods for the study of disease biomarkers, including molecular types and their clinical utilities.
  • Organisations: End-users organisations include clinics or hospitals, government bodies, large international companies, research institutes, small and medium sized companies, universities and veterinary centres.
  • Fields: End-users underlying fields include biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and universities.
  • Bioinformatics Software: End-users' disclosures on their preferred bioinformatics software, associated with DNA microarray studies.
  • Purpose: End-users' underlying reasons for using DNA microarray analysis across 13 major fields (biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security, university), each ranked according to their relative importance.
  • Samples: Study sample types analysed by end-users using DNA microarray methods, each ranked according to their relative importance.
  • Sample Preparation: The use of sample preparation methods by end-users for DNA microarray studies, each ranked according to their importance. 

Executive Summary

Chapter 1 Introduction

Chapter 2 Study Participants

2.1 This Chapter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 0.00 0.00%
S&P 500 1,878.61 +3.22 0.17%
NASDAQ 4,148.3380 +21.3710 0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs